SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO
Akero Therapeutics Inc AKRO
News
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO
Ademi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc.
Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Behalf of Akero Therapeutics Shareholders
AKRO Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Akero Therapeutics (NASDAQ:AKRO)
Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Behalf of Shareholders
Madrigal's stock surges as FDA approves first drug for liver disease MASH
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
Akero Therapeutics Announces Proposed Public Offering of Common Stock
Thinking about buying stock in MMTec, Ainos, Jumia Technologies, Akero Therapeutics, or BioVie?
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
Akero Therapeutics to Present Topline Week 96 Results from Phase 2b HARMONY Study Investigating Efruxifermin in Patients with Pre-Cirrhotic MASH
Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Thinking about buying stock in Beneficient, Warby Parker, Akero Therapeutics, Masco, or Nextdoor Holdings?
Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Behalf of Akero Therapeutics Shareholders
Akero Therapeutics shares plunge on liver disease treatment's mixed results
Weight-loss drugs in development aim to replace injections with pills